Sanofi (SNY) Q2 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Hello everyone, this is Thomas Kudsk Larsen from the Zenofi IR team. Welcome to the second quarter 2026 conference call for investors and analysts. Fires can be found on zenofi.com. Please turn to slide number three. Here are the forward-looking statements. We would like to remind you that information presented in this call contains forward-looking statements which are subject to substantial risk and uncertainties that may cause actual results to differ materially. We encourage you to read the disclaimer in the presentation. We also refer you to our Form 20F on file with the US SEC and our French Universal Registration Document. We're going to make comments on our performance using constant exchange rates and other non-IFRS measures. Numbers used are in millions of euros and for the second quarter, unless we state it otherwise. Please turn to slide number four. Here is the agenda for today. We are welcoming Berlin for the first quarterly conference call since joining Sanofi. Berlin will cover our business and its first reflections as a new CEO. You'll also hear from our CFO, François, and our head of research, Mike, on the pipeline. We've expanded to one hour and 15 minutes to allow for the new CEO update and plenty of Q&A. For the Q&A, we also have the support of Manuela, Olivier and Thomas to cover our global business, as well as Roy, our general counsel. You can participate in two ways, either raise your hand in Zoom or submit your question using the Q&A feature. And with this, I now hand over to Belen. Thank you, Thomas. Welcome, everybody, also from my side. As you can imagine, I'm excited to return to Sanofi, ready to drive the necessary improvement and lead the organization in its next phase of growth. I'm also looking forward to reconnecting with all of you o...